Patents by Inventor Federico Cozzolino

Federico Cozzolino has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS FOR THE TREATMENT OF ISCHEMIA-REPERFUSION-RELATED DISEASES
    Publication number: 20180155363
    Abstract: The present invention relates to compounds of formula (I) useful in the treatment of ischemia-reperfusion-related pathologies.
    Type: Application
    Filed: December 12, 2017
    Publication date: June 7, 2018
    Inventors: Antonio Guarna, Federico Cozzolino
  • Compounds for the treatment of ischemia-reperfusion-related diseases
    Patent number: 9932352
    Abstract: The present invention relates to compounds of formula (I) useful in the treatment of ischemia-reperfusion-related pathologies.
    Type: Grant
    Filed: March 20, 2013
    Date of Patent: April 3, 2018
    Assignee: MINERVA PATENTS S.A.
    Inventors: Antonio Guarna, Federico Cozzolino
  • COMPOUNDS FOR THE TREATMENT OF ISCHEMIA-REPERFUSION-RELATED DISEASES
    Publication number: 20150080388
    Abstract: The present invention relates to compounds of formula (I) useful in the treatment of ischemia-reperfusion-related pathologies.
    Type: Application
    Filed: March 20, 2013
    Publication date: March 19, 2015
    Inventors: Antonio Guarna, Federico Cozzolino
  • Pharmaceutical compositions for the treatment of diseases related to neurotrophines
    Patent number: 7625892
    Abstract: The present invention refers to pharmaceutical preparations including as active compounds 3-aza-bicyclo[3.2.1]octane derivatives of general formula (I) and/or their dimers of general formula (II) and (III) acting as agonists of human neurotrophines. Therefore, such compounds of formula (I), (II) and (III) are useful for treatment of diseases in which the neurotrophine functions are involved in defect, particularly of Nerve Growth Factor (NGF), such as neurodegenerative diseases of central nervous system (CNS), acquired immunodeficiency due to a reduced NGF biodisponibility, or morbous conditions in which the stimulus of neoangiogenesis process is convenient.
    Type: Grant
    Filed: June 18, 2003
    Date of Patent: December 1, 2009
    Assignee: Mimetech S.r.l.
    Inventors: Antonio Guarna, Federico Cozzolino, Maria Torcia, Enrico Garaci
  • Pharmaceutical compositions for the treatment of diseases related to neurotrophines
    Publication number: 20060069092
    Abstract: The present invention refers to pharmaceutical preparations including as active compounds 3-aza-bicyclo[3.2.1]octane derivatives of general formula (I) and/or their dimers of general formula (II) and (III) acting as agonists of human neurotrophines. Therefore, such compounds of formula (I), (II) and (III) are useful for treatment of diseases in which the neurotrophine functions are involved in defect, particularly of Nerve Growth Factor (NGF), such as neurodegenerative diseases of central nervous system (CNS), acquired immunodeficiency due to a reduced NGF biodisponibility, or morbous conditions in which the stimulus of neoangiogenesis process is convenient.
    Type: Application
    Filed: June 18, 2003
    Publication date: March 30, 2006
    Inventors: Antonio Guarna, Federico Cozzolino, Marcia Torcia, Enrico Garaci